Literature DB >> 901737

Effect of clofibrate on glucose tolerance in maturity onset diabetes.

D Barnett, J G Craig, D S Robinson, M P Rogers.   

Abstract

1 Fourteen maturity onset diabetics showed improvement of glucose tolerance while on treatment with clofibrate. Fasting blood glucose levels were reduced by 20% after treatment for 14 and 28 days. 2 The effect was found to be independent of concurrent treatment with oral hypoglycaemic drugs. 3 Plasma insulin levels were also lower during clofibrate treatment. 4 Clofibrate may prove to be a useful adjunct to the treatment of maturity onset diabetes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901737      PMCID: PMC1429057          DOI: 10.1111/j.1365-2125.1977.tb00761.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  ATROMID IN THE TREATMENT OF POST-CLIMACTERIC DIABETES.

Authors:  R D MILLER
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  THE EFFECT OF ATROMID ON SERUM CHOLESTEROL AND GLUCOSE TOLERANCE IN DIABETES MELLITUS.

Authors:  S C HERRIOT; I W PERCY-ROBB; J A STRONG; C G THOMSON
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

3.  AN EXPERIMENTAL APPROACH TO THE PROBLEM OF DISORDERED LIPID METABOLISM.

Authors:  J M THORP
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

4.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

5.  Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles.

Authors:  P J Randle; E A Newsholme; P B Garland
Journal:  Biochem J       Date:  1964-12       Impact factor: 3.857

6.  Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.

Authors:  R W Fenderson; I Sekowski; C Mohan; S Deutsch; F Benjamin; P Samuel
Journal:  Am J Clin Nutr       Date:  1974-01       Impact factor: 7.045

7.  Laboratory indices in clofibrate therapy of juvenile-onset diabetes.

Authors:  J V Narduzzi; T S Danowski; T F Weir; R A Alley; J W Vester; C Moses
Journal:  Clin Pharmacol Ther       Date:  1967 Nov-Dec       Impact factor: 6.875

8.  Effect of CPIB ester on plasma free fatty acid levels in man.

Authors:  B M Rifkind
Journal:  Metabolism       Date:  1966-08       Impact factor: 8.694

9.  A colorimetric method for estimating serum triglycerides.

Authors:  M J Fletcher
Journal:  Clin Chim Acta       Date:  1968-11       Impact factor: 3.786

10.  Long-term treatment of hyperlipidemic patients with clofibrate.

Authors:  D Berkowitz
Journal:  JAMA       Date:  1971-11-15       Impact factor: 56.272

View more
  8 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

Review 3.  Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?

Authors:  Jeny Laskar; Kasturi Bhattacharjee; Mahuya Sengupta; Yashmin Choudhury
Journal:  Pathol Oncol Res       Date:  2018-03-13       Impact factor: 3.201

Review 4.  Drug-induced hypoglycaemia: an update.

Authors:  Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

5.  Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus.

Authors:  K Murakami; S Nambu; H Koh; M Kobayashi; Y Shigeta
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

6.  Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.

Authors:  J C Daubresse; D Daigneux; M Bruwier; A Luyckx; P J Lefebvre
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

7.  Modification of intracellular glucose metabolism in human skin fibroblast preincubated with p-chlorophenoxyisobutyrate.

Authors:  T Nishide; K Shirai; Y Saito; S Yoshida
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

8.  Clofibrate inhibits the umami-savory taste of glutamate.

Authors:  Matthew Kochem; Paul A S Breslin
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.